Oppenheimer & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,398
| Closed | -$205K | – | 1451 |
|
|
2023
Q1 | $205K | Hold |
1,398
| – | – | ﹤0.01% | 1259 |
|
|
2022
Q4 | $223K | Sell |
1,398
-218
| -13% | -$34.7K | 0.01% | 1198 |
|
|
2022
Q3 | $215K | Sell |
1,616
-338
| -17% | -$45K | 0.01% | 1201 |
|
|
2022
Q2 | $305K | Hold |
1,954
| – | – | 0.01% | 1102 |
|
|
2022
Q1 | $304K | Hold |
1,954
| – | – | 0.01% | 1196 |
|
|
2021
Q4 | $249K | Sell |
1,954
-17
| -0.9% | -$2.17K | ﹤0.01% | 1305 |
|
|
2021
Q3 | $257K | Sell |
1,971
-59
| -3% | -$7.69K | ﹤0.01% | 1282 |
|
|
2021
Q2 | $361K | Buy |
2,030
+94
| +5% | +$16.7K | 0.01% | 1165 |
|
|
2021
Q1 | $318K | Sell |
1,936
-65
| -3% | -$10.7K | 0.01% | 1147 |
|
|
2020
Q4 | $330K | Hold |
2,001
| – | – | 0.01% | 1056 |
|
|
2020
Q3 | $285K | Sell |
2,001
-188
| -9% | -$26.8K | 0.01% | 1002 |
|
|
2020
Q2 | $242K | Sell |
2,189
-478
| -18% | -$52.8K | 0.01% | 1045 |
|
|
2020
Q1 | $266K | Buy |
+2,667
| New | +$266K | 0.01% | 940 |
|
|
2017
Q1 | – | Sell |
-3,497
| Closed | -$381K | – | 1319 |
|
|
2016
Q4 | $381K | Buy |
+3,497
| New | +$381K | 0.01% | 902 |
|
|
2015
Q4 | – | Sell |
-1,762
| Closed | -$234K | – | 1322 |
|
|
2015
Q3 | $234K | Sell |
1,762
-2,781
| -61% | -$369K | 0.01% | 1096 |
|
|
2015
Q2 | $800K | Sell |
4,543
-6,416
| -59% | -$1.13M | 0.02% | 700 |
|
|
2015
Q1 | $1.89M | Buy |
10,959
+6,773
| +162% | +$1.17M | 0.05% | 416 |
|
|
2014
Q4 | $685K | Buy |
4,186
+1,537
| +58% | +$252K | 0.02% | 719 |
|
|
2014
Q3 | $425K | Sell |
2,649
-2,449
| -48% | -$393K | 0.01% | 917 |
|
|
2014
Q2 | $750K | Buy |
5,098
+2,515
| +97% | +$370K | 0.02% | 716 |
|
|
2014
Q1 | $358K | Sell |
2,583
-614
| -19% | -$85.1K | 0.01% | 971 |
|
|
2013
Q4 | $405K | Sell |
3,197
-348
| -10% | -$44.1K | 0.01% | 899 |
|
|
2013
Q3 | $326K | Sell |
3,545
-135
| -4% | -$12.4K | 0.01% | 942 |
|
|
2013
Q2 | $253K | Buy |
+3,680
| New | +$253K | 0.01% | 1000 |
|